MGMT and glioblastoma: (8) reported recurrence patterns after concurrent radiotherapy and chemotherapy in 105 glioblastoma patients; 64 and 31% of MGMT-methylated patients had central/in-field and distant recurrence, respectively, in contrast to 91% and 5.4% of unmethylated patients.